Governmental Regulations and Increasing Food and Drug Administration Oversight of Regenerative Medicine Products: What’s New in 2020?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Governmental Regulations and Increasing Food and Drug Administration Oversight of Regenerative Medicine Products: What’s New in 2020?

Published:2020-10 Issue:10 Volume:36 Page:2765-2770
ISSN:0749-8063
Container-title:Arthroscopy: The Journal of Arthroscopic & Related Surgery
language:en
Short-container-title:Arthroscopy: The Journal of Arthroscopic & Related Surgery

Author:

Fang William H.,Vangsness C. Thomas

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine

Reference26 articles.

1. Early development in the regulation of biologics;Coleman;Food Drug Law J,2016

2. Application of biologics in the treatment of the rotator cuff, meniscus, cartilage, and osteoarthritis;Anz;J Am Acad Orthop Surg,2014

3. Intra-articular mesenchymal stem cell therapy for the human joint: A systematic review;McIntyre;Am J Sports Med,2018

4. Regulation: Sell help not hope;Bianco;Nature,2014

5. Stem cell science: Current ethical and policy issues;Mauron;Clin Pharmacol Ther,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standardisation is the key to the sustained, rapid and healthy development of stem cell‐based therapy;Clinical and Translational Medicine;2024-04

2. Management of Articular Cartilage Defects in the Knee: An Evidence-Based Algorithm;JBJS Journal of Orthopaedics for Physician Assistants;2024-04

3. Regulatory Aspects of Regenerative Therapy and Stem Cell Therapy: Current Perspectives;Essentials of Regenerative Medicine in Interventional Pain Management;2024

4. Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies;Regenerative Medicine;2023-10-23

5. Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies;Regenerative Medicine;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3